Latest Breaking News On - Rajeshk rajpal - Page 1 : vimarsana.com
US drug pricing landscape tops 2023 ophthalmic business news
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Vision Innovation Partners Completes 20th Acquisition
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
New Prospective Study Shows Significant Reduction In Reports Of Postoperative Halos From Patients Treated With TearScience LipiFlow Treatment Prior To Bilateral Cataract Surgery - Press Release
wiredprnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiredprnews.com Daily Mail and Mail on Sunday newspapers.
New Prospective Study Shows Significant Reduction In Reports Of Postoperative Halos From Patients Treated With TearScience LipiFlow Treatment Prior To Bilateral Cataract Surgery
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SANTA ANA, Calif., April 21, 2021 /PRNewswire/ Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies , today announced the FDA 510(k) clearance and CE mark of its next-generation phacoemulsification innovation, the VERITAS™ Vision System
1. The high-performance phacoemulsification system features technologies that allow surgeons to guide through any lens density with less surge and more stability. The new system also provides advancements in ergonomics to further enhance usability during cataract surgery.
(PRNewsfoto/Johnson & Johnson Vision)
More than 90% of people develop cataracts by the age of 65,
2 and cataract surgery is one of the most common outpatient procedures performed today with a success rate of approximately 98%.